Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Amortization - Deferred ChargesEBIATMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Fennec Pharmaceuticals (FENC) Non-Current Receivables (2025)

Fennec Pharmaceuticals' Non-Current Receivables history spans 1 years, with the latest figure at $2.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Receivables changed N/A year-over-year to $2.8 million, compared with a TTM value of $2.8 million through Dec 2025, changed N/A, and an annual FY2025 reading of $2.8 million, changed N/A over the prior year.
  • Non-Current Receivables for Q4 2025 was $2.8 million at Fennec Pharmaceuticals, up from $2.5 million in the prior quarter.
  • The five-year high for Non-Current Receivables was $3.3 million in Q2 2025, with the low at $2.5 million in Q3 2025.